Are breast cancer patients with low distress at diagnosis at risk of psychological symptoms later in their disease trajectory? Considerations for when to screen for distress
DOI:
https://doi.org/10.2340/1651-226X.2025.42367Keywords:
Breast cancer, cancer survivorship, symptom trajectories, psychological distressAbstract
Introduction: To target psychological support to cancer patients most in need of support, screening for psychological distress has been advocated and, in some settings, also implemented. Still, no prior studies have examined the appropriate ‘dosage’ and whether screening for distress before cancer treatment may be sufficient or if further screenings during treatment are necessary. We examined the development in symptom trajectories for breast cancer patients with low distress before surgery and explored potential risk factors for developing burdensome symptoms at a later point in time.
Methods: In total, 299 patients newly diagnosed with breast cancer who scored < 7 on the distress thermometer were included between August 2017 and October 2019 at the Department of Breast Surgery, Rigshospitalet, Copenhagen. Patients were followed through electronic questionnaires at baseline before surgery and after 6, 12, and 18 months. We used latent class mixed models to identify sub-groups of patients with similar development in distress, anxiety, depression, breast cancer-specific health-related quality of life, self-efficacy, and fear of recurrence over time. Logistic and multinomial regression analyses were applied to examine clinical and sociodemographic factors associated with specific symptom trajectories.
Results: We did not identify any sub-groups of women with low distress at diagnosis who developed disabling psychological symptoms up to 18 months after diagnosis. However, we did identify a sub-group of 52% of the women who experienced persistent mild anxiety (Generalised Anxiety Disorder [GAD]-7 score 5–9). Adjusted for baseline treatment modalities and sociodemographic characteristics, women having low social support (odds ratio [OR]: 2.90; 95% confidence interval [CI]: 1.07–7.87) or living with a partner (OR: 3.18; 95% CI: 1.38–7.34) were more likely to experience persistent mild anxiety.
Interpretation: The results show that the majority of women with low distress at breast cancer diagnosis do not experience an increase in psychological symptoms over time. Screening for distress at cancer diagnosis may be an essential step to identify most breast cancer patients in need of professional support for psychological symptoms.
Downloads
References
Bidstrup PE, Christensen J, Mertz BG, Rottmann N, Dalton SO, Johansen C. Trajectories of distress, anxiety, and depression among women with breast cancer: looking beyond the mean. Acta Oncol (Stockholm, Sweden). 2015;54(5):789–96.
https://doi.org/10.3109/0284186X.2014.1002571 DOI: https://doi.org/10.3109/0284186X.2014.1002571
Nielsen AWM, Lundorff M, Nielsen HM, Alsner J, Vrou Offersen B, Kristensen MH, et al. Symptom trajectories in breast cancer survivors: growth mixture analysis of patient-reported pain, fatigue, insomnia, breast and arm symptoms. Acta Oncol (Stockholm, Sweden). 2021;60(12):1659–67.
https://doi.org/10.1080/0284186X.2021.1981550 DOI: https://doi.org/10.1080/0284186X.2021.1981550
Mausbach BT, Schwab RB, Irwin SA. Depression as a predictor of adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2015;152(2):239–46.
https://doi.org/10.1007/s10549-015-3471-7 DOI: https://doi.org/10.1007/s10549-015-3471-7
Eliassen FM, Blåfjelldal V, Helland T, Hjorth CF, Hølland K, Lode L, et al. Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review. BMC Cancer. 2023;23(1):625.
https://doi.org/10.1186/s12885-023-11122-8 DOI: https://doi.org/10.1186/s12885-023-11122-8
Schouten B, Avau B, Bekkering GTE, Vankrunkelsven P, Mebis J, Hellings J, et al. Systematic screening and assessment of psychosocial well-being and care needs of people with cancer. Cochrane Database Syst Rev. 2019;3(3):CD012387.
https://doi.org/10.1002/14651858.CD012387.pub2 DOI: https://doi.org/10.1002/14651858.CD012387.pub2
Riba MB, Donovan KA, Ahmed K, Andersen B, Braun I, Breitbart WS, et al. NCCN Guidelines® Insights: dstress management, version 2.2023. J Natl Comprehen Cancer Network. 2023;21(5):450–7.
https://doi.org/10.6004/jnccn.2023.0026 DOI: https://doi.org/10.6004/jnccn.2023.0026
Donovan KA, Grassi L, Deshields TL, Corbett C, Riba MB. Advancing the science of distress screening and management in cancer care. Epidemiol Psychiatr Sci. 2020;29:e85.
https://doi.org/10.1017/S2045796019000799 DOI: https://doi.org/10.1017/S2045796019000799
Bidstrup PE, Johansen C, Kroman N, Belmonte F, Duriaud H, Dalton S, et al. Effekt of a nurse navigation intervention on mental symptoms in patients with psychological vulnerability and breast cancer: the REBECCA randomized clinical trial. JAMA Netw Open. 2023;6(6):e2319591.
https://doi.org/10.1001/jamanetworkopen.2023.19591 DOI: https://doi.org/10.1001/jamanetworkopen.2023.19591
McCarter K, Britton B, Baker AL, Halpin SA, Beck AK, Carter G, et al. Interventions to improve screening and appropriate referral of patients with cancer for psychosocial distress: systematic review. BMJ Open. 2018;8(1):e017959.
https://doi.org/10.1136/bmjopen-2017-017959 DOI: https://doi.org/10.1136/bmjopen-2017-017959
Stanton AL, Wiley JF, Krull JL, Crespi CM, Hammen C, Allen JJ, et al. Depressive episodes, symptoms, and trajectories in women recently diagnosed with breast cancer. Breast Cancer Res Treat. 2015;154(1):105–15.
https://doi.org/10.1007/s10549-015-3563-4 DOI: https://doi.org/10.1007/s10549-015-3563-4
Rottmann N, Hansen DG, Hagedoorn M, Larsen PV, Nicolaisen A, Bidstrup PE, et al. Depressive symptom trajectories in women affected by breast cancer and their male partners: a nationwide prospective cohort study. J Cancer Survivors Res Pract. 2016;10(5):915–26.
https://doi.org/10.1007/s11764-016-0538-3 DOI: https://doi.org/10.1007/s11764-016-0538-3
Park JH, Chun M, Jung YS, Bae SH. Predictors of psychological distress trajectories in the first year after a breast cancer diagnosis. Asian Nurs Res (Korean Soc Nurs Sci). 2017;11(4):268–75.
https://doi.org/10.1016/j.anr.2017.10.003 DOI: https://doi.org/10.1016/j.anr.2017.10.003
Crane TE, Badger TA, Sikorskii A, Segrin C, Hsu CH, Rosenfeld AG. Trajectories of depression and anxiety in Latina breast cancer survivors. Oncol Nurs Forum. 2019;46(2):217–27.
https://doi.org/10.1188/19.ONF.217-227 DOI: https://doi.org/10.1188/19.ONF.217-227
Lam WW, Soong I, Yau TK, Wong KY, Tsang J, Yeo W, et al. The evolution of psychological distress trajectories in women diagnosed with advanced breast cancer: a longitudinal study. Psycho-Oncology. 2013;22(12):2831–9.
https://doi.org/10.1002/pon.3361 DOI: https://doi.org/10.1002/pon.3361
Charles C, Bardet A, Larive A, Gorwood P, Ramoz N, Thomas E, et al. Characterization of depressive symptoms trajectories after breast cancer diagnosis in women in France. JAMA Netw Open. 2022;5(4):e225118.
https://doi.org/10.1001/jamanetworkopen.2022.5118 DOI: https://doi.org/10.1001/jamanetworkopen.2022.5118
Nakamura ZM, Small BJ, Zhai W, Ahles TA, Ahn J, Artese AL, et al. Depressive symptom trajectories in older breast cancer survivors: the Thinking and Living with Cancer Study. J Cancer Survivors Res Pract. 2023 Nov 4. [Epub ahead of print] https://doi.org/10.1007/s11764-023-01490-2 DOI: https://doi.org/10.1007/s11764-023-01490-2
Karademas EC, Mylona E, Mazzocco K, Pat-Horenczyk R, Sousa B, Oliveira-Maia AJ, et al. Well-being trajectories in breast cancer and their predictors: a machine-learning approach. Psycho-Oncology. 2023;32(11):1762–70.
https://doi.org/10.1002/pon.6230 DOI: https://doi.org/10.1002/pon.6230
Proust-Lima C, Amieva H, Jacqmin-Gadda H. Analysis of multivariate mixed longitudinal data: a flexible latent process approach. Br J Math Stat Psychol. 2013;66(3):470–87.
https://doi.org/10.1111/bmsp.12000 DOI: https://doi.org/10.1111/bmsp.12000
Bonanno GA. Loss, trauma, and human resilience: have we underestimated the human capacity to thrive after extremely aversive events? Am Psychol. 2004;59(1):20–8.
https://doi.org/10.1037/0003-066X.59.1.20 DOI: https://doi.org/10.1037/0003-066X.59.1.20
Brandão T, Schulz MS, Matos PM. Psychological adjustment after breast cancer: a systematic review of longitudinal studies. Psycho-Oncology. 2017;26(7):917–26.
https://doi.org/10.1002/pon.4230 DOI: https://doi.org/10.1002/pon.4230
Ulibarri-Ochoa A, Macía P, Ruiz-de-Alegría B, García-Vivar C, Iraurgi I. The role of resilience and coping strategies as predictors of well-being in breast cancer patients. Eur J Oncol Nurs. 2024;71:102620.
https://doi.org/10.1016/j.ejon.2024.102620 DOI: https://doi.org/10.1016/j.ejon.2024.102620
Ganz PA, Kwan L, Stanton AL, Bower JE, Belin TR. Physical and psychosocial recovery in the year after primary treatment of breast cancer. J Clin Oncol. 2011;29(9):1101–9.
https://doi.org/10.1200/JCO.2010.28.8043 DOI: https://doi.org/10.1200/JCO.2010.28.8043
Karlsen RV, Frederiksen K, Larsen MB, Von Heymann-Horan AB, Appel CW, Christensen J, et al. The impact of a breast cancer diagnosis on health-related quality of life. A prospective comparison among middle-aged to elderly women with and without breast cancer. Acta Oncol (Stockholm, Sweden). 2016;55(6):720–7.
https://doi.org/10.3109/0284186X.2015.1127415 DOI: https://doi.org/10.3109/0284186X.2015.1127415
Goyal NG, Levine BJ, Van Zee KJ, Naftalis E, Avis NE. Trajectories of quality of life following breast cancer diagnosis. Breast Cancer Res Treat. 2018;169(1):163–73.
https://doi.org/10.1007/s10549-018-4677-2 DOI: https://doi.org/10.1007/s10549-018-4677-2
Park JH, Jung YS, Kim JY, Bae SH. Trajectories of quality of life in breast cancer survivors during the first year after treatment: a longitudinal study. BMC Womens Health. 2023;23(1):12.
https://doi.org/10.1186/s12905-022-02153-7 DOI: https://doi.org/10.1186/s12905-022-02153-7
Wu F, Howell D, Fang Q, Chen J, Yuan C. Trajectory patterns and factors influencing self-management behaviors in Chinese patients with breast cancer. Cancer Nurs. 2020;43(2):E105–e12.
https://doi.org/10.1097/NCC.0000000000000681 DOI: https://doi.org/10.1097/NCC.0000000000000681
Chirico A, Lucidi F, Merluzzi T, Alivernini F, Laurentiis M, Botti G, et al. A meta-analytic review of the relationship of cancer coping self-efficacy with distress and quality of life. Oncotarget. 2017;8(22):36800–11.
https://doi.org/10.18632/oncotarget.15758 DOI: https://doi.org/10.18632/oncotarget.15758
White LL, Cohen MZ, Berger AM, Kupzyk KA, Bierman PJ. Self-efficacy for management of symptoms and symptom distress in adults with cancer: an integrative review. Oncol Nurs Forum. 2019;46(1):113–28.
https://doi.org/10.1188/19.ONF.113-128 DOI: https://doi.org/10.1188/19.ONF.113-128
Dunn LB, Langford DJ, Paul SM, Berman MB, Shumay DM, Kober K, et al. Trajectories of fear of recurrence in women with breast cancer. Support Care Cancer. 2015;23(7):2033–43.
https://doi.org/10.1007/s00520-014-2513-8 DOI: https://doi.org/10.1007/s00520-014-2513-8
Schapira L, Zheng Y, Gelber SI, Poorvu P, Ruddy KJ, Tamimi RM, et al. Trajectories of fear of cancer recurrence in young breast cancer survivors. Cancer. 2022;128(2):335–43.
https://doi.org/10.1002/cncr.33921 DOI: https://doi.org/10.1002/cncr.33921
Mello S, Tan AS, Armstrong K, Sanford Schwartz J, Hornik RC. Anxiety and depression among cancer survivors: the role of engagement with sources of emotional support information. Health Commun. 2013;28(4):389–96.
https://doi.org/10.1080/10410236.2012.690329 DOI: https://doi.org/10.1080/10410236.2012.690329
Götz A, Kröner A, Jenewein J, Spirig R. Evaluation of the adherence of distress screening with the distress thermometer in cancer patients 4 years after implementation. Support Care Cancer. 2019;27(8):2799–807.
https://doi.org/10.1007/s00520-018-4579-1 DOI: https://doi.org/10.1007/s00520-018-4579-1
Deshields TL, Wells-Di Gregorio S, Flowers SR, Irwin KE, Nipp R, Padgett L, et al. Addressing distress management challenges: recommendations from the consensus panel of the American Psychosocial Oncology Society and the Association of Oncology Social Work. CA Cancer J Clin. 2021;71(5):407–36.
https://doi.org/10.3322/caac.21672 DOI: https://doi.org/10.3322/caac.21672
Rohan EA, Boehm JE, Samarasinha R, Stachon K, Gallaway MS, Huang G, et al. Diving deeper into distress screening implementation in oncology care. J Psychosoc Oncol. 2023;41(6):645–60.
https://doi.org/10.1080/07347332.2023.2250774 DOI: https://doi.org/10.1080/07347332.2023.2250774
Ebbestad FE, Ammitzbøll G, Horsbøll TA, Andersen I, Johansen C, Zehran B, et al. The long-term burden of a symptom cluster and association with longitudinal physical and emotional functioning in breast cancer survivors. Acta Oncol (Stockholm, Sweden). 2023;62(7):706–13.
https://doi.org/10.1080/0284186X.2023.2185909 DOI: https://doi.org/10.1080/0284186X.2023.2185909
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Rikke Langballe, Birgitte Mertz, Niels Kroman, Thomas Maltesen, Susanne Rosthøj, Pernille Envold Bidstrup
This work is licensed under a Creative Commons Attribution 4.0 International License.
